INFY Stock Analysis: Infosys | NYSE
Information Technology Services | NYSE, USA | Market Cap: 48.966m USD | 12M Return: -25.2% | US4567881085 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 263M
EPS Trend: 88.4%
Qual. Beats: -1
Rev. Trend: 98.4%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Infosys Limited (NYSE: INFY) is an India-headquartered global provider of consulting, technology, outsourcing, and digital services, operating within the IT Consulting & Other Services segment of the Information Technology sector. The company serves clients across more than 30 industries, including financial services, healthcare, manufacturing, retail, and energy, reflecting the broad-based client diversification typical of large-scale Indian IT services firms.
Its service portfolio spans digital transformation, data analytics, applied and generative AI, cloud computing, cybersecurity, enterprise application solutions (Oracle, SAP, Salesforce), and industry-specific platforms. Flagship offerings include Topaz, an AI-first services suite built on generative AI technologies, and Finacle, a widely deployed core banking solution used by banks globally.
Beyond services, Infosys maintains a portfolio of proprietary digital platforms such as Panaya, Infosys Wingspan, and the Infosys Meridian and Cortex suites, and operates the Infosys McCamish insurance platform. The company holds strategic collaborations with Anthropic PBC, Intel, and Harness Inc., supporting its push into AI and developer productivity tooling.
Founded in 1981 and headquartered in Bengaluru, Infosys was originally incorporated as Infosys Technologies Limited and adopted its current name in June 2011. Its ADR trades on the NYSE following a March 1999 listing, and it remains one of the largest publicly listed Indian IT services exporters.
- BFSI segment revenue grows on US bank IT spending recovery
- Generative AI deal momentum accelerates via Topaz platform and Anthropic partnership
- Wage inflation and visa costs pressure operating margins
| Net Income: 3.32b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.23 > 0.02 and ΔFCF/TA 0.76 > 1.0 |
| NWC/Revenue: 23.73% < 20% (prev 31.23%; Δ -7.50% < -1%) |
| CFO/TA 0.25 > 3% & CFO 4.11b > Net Income 3.32b |
| Net Debt (-1.64b) to EBITDA (5.13b): -0.32 < 3 |
| Current Ratio: 1.86 > 1.5 & < 3 |
| Outstanding Shares: last quarter (4.09b) vs 12m ago -1.34% < -2% |
| Gross Margin: 30.32% > 18% (prev 30.46%; Δ -0.14% > 0.5%) |
| Asset Turnover: 120.1% > 50% (prev 111.8%; Δ 8.32% > 0%) |
| Interest Coverage Ratio: 95.82 > 6 (EBIT TTM 4.58b / Interest Expense TTM 47.8m) |
| A: 0.29 (Total Current Assets 10.4b - Total Current Liabilities 5.59b) / Total Assets 16.4b |
| B: 0.50 (Retained Earnings 8.18b / Total Assets 16.4b) |
| C: 0.27 (EBIT TTM 4.58b / Avg Total Assets 16.9b) |
| D: 1.44 (Book Value of Equity 9.62b / Total Liabilities 6.68b) |
| Altman-Z'' = 6.89 = AAA |
| DSRI: 0.95 (Receivables 5.33b/5.37b, Revenue 20.3b/19.5b) |
| GMI: 1.00 (GM 30.46% / 30.32%) |
| AQI: 1.04 (AQ_t 0.24 / AQ_t-1 0.23) |
| SGI: 1.04 (Revenue 20.3b / 19.5b) |
| TATA: -0.05 (NI 3.32b - CFO 4.11b) / TA 16.4b) |
| Beneish M = -3.01 (Cap -4..+1) = AA |
As of August 19, 2026, the stock is trading at USD 11.83 with a total of 16,892,215 shares traded. Over the past week, the price has changed by -6.11%, over one month by +4.60%, over three months by -4.01% and over the past year by -25.24%.
Current recommended Stop Loss: 11.10 (which is 6.2% or 1.7 ATR below the current price).
Infosys has received a consensus analysts rating of 3.71. Therefore, it is recommended to hold INFY.
- StrongBuy: 4
- Buy: 2
- Hold: 8
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 11.9 | 0.2% |
P/E Trailing = 14.9259
P/E Forward = 15.015
P/S = 2.4122
P/B = 5.0905
P/EG = 2.0557
Revenue TTM = 20.3b USD
EBIT TTM = 4.58b USD
EBITDA TTM = 5.13b USD
Long Term Debt = 563.0m USD (estimated: total debt 923.0m - short term 360.0m)
Short Term Debt = 360.0m USD (from shortTermDebt, last quarter)
Debt = 1.49b USD (from shortLongTermDebtTotal, last quarter) + Leases 563.0m
Net Debt = -1.64b USD (calculated: Debt 1.49b - CCE 3.12b)
Enterprise Value = 47.3b USD (49.0b + Debt 1.49b - CCE 3.12b)
Interest Coverage Ratio = 95.82 (Ebit TTM 4.58b / Interest Expense TTM 47.8m)
EV/FCF = 12.39x (Enterprise Value 47.3b / FCF TTM 3.82b)
FCF Yield = 8.07% (FCF TTM 3.82b / Enterprise Value 47.3b)
FCF Margin = 18.82% (FCF TTM 3.82b / Revenue TTM 20.3b)
Net Margin = 16.38% (Net Income TTM 3.32b / Revenue TTM 20.3b)
Gross Margin = 30.32% ((Revenue TTM 20.3b - Cost of Revenue TTM 14.1b) / Revenue TTM)
Gross Margin QoQ = 31.48% (prev 30.85%)
Tobins Q-Ratio = 2.89 (Enterprise Value 47.3b / Total Assets 16.4b)
Interest Expense / Debt = 3.22% (Interest Expense 47.8m / Debt 1.49b)
Taxrate = 26.57% (1.20b / 4.53b)
NOPAT = 3.36b (EBIT 4.58b * (1 - 26.57%))
Current Ratio = 1.86 (Total Current Assets 10.4b / Total Current Liabilities 5.59b)
Debt / Equity = 0.15 (Debt 1.49b / totalStockholderEquity, last quarter 9.62b)
Debt / EBITDA = -0.32 (Net Debt -1.64b / EBITDA 5.13b)
Debt / FCF = -0.43 (Net Debt -1.64b / FCF TTM 3.82b)
Total Stockholder Equity = 10.1b (last 4 quarters mean from totalStockholderEquity)
RoA = 19.66% (Net Income 3.32b / Total Assets 16.4b)
RoE = 33.01% (Net Income TTM 3.32b / Total Stockholder Equity 10.1b)
RoCE = 43.07% (EBIT 4.58b / Capital Employed (Equity 10.1b + L.T.Debt 563.0m))
RoIC = 33.24% (NOPAT 3.36b / Invested Capital 10.1b)
WACC = 7.93% (E(49.0b)/V(50.5b) * Re(8.10%) + D(1.49b)/V(50.5b) * Rd(3.22%) * (1-Tc(0.27)))
Discount Rate = 8.10% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -31.99 | Cagr: -0.54%
[DCF] Terminal Value 75.01% ; FCFF base≈3.87b ; Y1≈3.78b ; Y5≈3.80b
[DCF] Fair Price = 15.10 (EV 59.5b - Net Debt -1.64b = Equity 61.1b / Shares 4.05b; r=8.35% [WACC [floored]]; 5y FCF grow -3.09% → 2.50% )
EPS Correlation: 88.40 | EPS CAGR: 4.94% | SUE: -1.32 | # QB: -1
Revenue Correlation: 98.35 | Revenue CAGR: 3.67% | SUE: -0.70 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.21 | Chg30d=-2.19% | Revisions=-29% | Analysts=7
EPS next Quarter (2026-12-31): EPS=0.20 | Chg30d=-3.07% | Revisions=-29% | Analysts=7
EPS current Year (2027-03-31): EPS=0.81 | Chg30d=-2.74% | Revisions=-50% | GrowthEPS=-3.0% | GrowthRev=+9.1%
EPS next Year (2028-03-31): EPS=0.85 | Chg30d=-4.13% | Revisions=-50% | GrowthEPS=+5.5% | GrowthRev=+3.8%
[Analyst] Revisions Ratio: -56% (up=4, down=18)